ASHP-Accredited since 2015
ASHP Program Code: 64039
National Matching Service Code: 171913
- Number of Residency Positions Available: 2
- Duration of Appointment: 13 month (first Monday in June to last Friday in June the following year)
- Salary: $46,188 for 13-month appointment
- Residents will staff 2 x 10 hour shifts every other weekend. Shifts will primarily occur in central pharmacy. Residents will be allowed one compensatory (comp) day off around weekends worked. Compensatory time off shall be used the Friday before or the Monday after the worked weekend. Outside of that designated time will be considered earned time off (ETO).
- Residents will work one major holiday and one minor holiday per department policy. These will be decided at the beginning of the residency year.
Resident Emergency Response
Residents will attend codes, level one strokes, and rapid responses throughout the hospital while on duty. The residents must obtain BLS, ACLS, and attend “Code Blue for Pharmacists” prior to attending codes. For level one stroke response, residents should complete the credentialing process for pharmacists and demonstrate knowledge of the alteplase procedures and the anticoagulation reversal protocol.
Code Blue/Rapid Response
Residents will attend all codes and rapid responses for patients that are on their service during normal rotation hours. At least one resident should respond for patients who are not on either resident’s service. The resident will initially serve as a back-up pharmacist, then assume lead-pharmacist responsibilities once deemed competent*. A preceptor will serve as a back-up pharmacist on codes until the resident has shown complete independence in managing codes. During emergency medicine rotations, the resident will respond with the ED pharmacist to all rapid responses and code blues throughout the house from 3:30 to 9:30 PM Monday through Friday.
Residents will respond to all level one strokes between the hours of 8:00 AM and 1:00 PM Monday through Friday. The resident will be responsible for assessing the patients for inclusion/exclusion criteria, going with the patient to CT, assessing the home medication list, and dosing/mixing alteplase in coordination with the medical team. If a bleed is identified on CT, the resident should coordinate with the physicians and central pharmacy for KCentra if indicated. The resident should remain with the patient until a decision is made about whether or not to treat.
On weekends, the resident staffing will be responsible for attending all codes, rapid responses, and level one strokes throughout the hospital for the 10 hours the resident is staffing. In addition, the resident should report to the ED upon request to assist with critical patients.
Residents should participate in team debriefing sessions following each code, if one is offered, in order to improve team performance. In addition, the resident should review each patient case with the attending pharmacist for the current rotation if applicable, or the critical care or ED pharmacist. Residents should be prepared to discuss what went well during the code and areas for improvement.
*Residents must demonstrate competence prior to any independent response. This may include discussions with the ED pharmacist, CC pharmacist, and the clinical coordinator, and completion of the EM I and/or CC I rotation. Final determination of competence will be made by the clinical coordinator.
All learning experience descriptions (LEDs) may be found in PharmAcademic.
Cox Medical Center Branson PGY-1 Pharmacy Residency Program 2020–2021
Required Block Rotations**
- Internal Medicine I
- Critical Care
- Emergency Medicine
- Rural Medicine- Monett
- Internal Medicine II
Elective Rotations (Choose Two)
- Ambulatory Care- Faith Community Health
- Critical Care II
- Emergency Medicine II
- Management block
- Others by request and availability**
- Teaching Certificate- UMKC online
**One additional off-site rotation is allowed, depending on preceptor availability. The rotation should be an experience not available at Branson; RPD has final approval.